A mechanism by which dietary trans fats cause atherosclerosis

Journal of Nutritional Biochemistry

Volumn 22, Issue 7, 2011, Pages 649-655

  Chen, Chun Lin ^a   Tetri, Laura H ^a   Neuschwander Tetri, Brent A ^a   Huang, Shuan Shian ^b   Huang, Jung San ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Auxagen Inc   (United States)

Author keywords

Aortic endothelium; Atherosclerosis; Cholesterol; Suppressed TGF responsiveness; Trans fats

Indexed keywords

SMAD2 PROTEIN; TRANS FATTY ACID; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CELL MEMBRANE; CONTROLLED STUDY; LIPID DIET; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; DIETARY FATS; ENDOTHELIUM, VASCULAR; HYPERCHOLESTEROLEMIA; LIVER; MALE; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MYOCARDIUM; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANS FATTY ACIDS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; MUS;

EID: 79958785649     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.05.004     Document Type: Article

References (38)

1. Emken E.A. Nutrition and biochemistry of trans and positional fatty acid isomers in hydrogenated oils. Annu Rev Nutr 1984, 4:339-376.
2. Korver O., Katan M.B. The elimination of trans fats from spreads: how science helped to turn an industry around. Nutr Rev 2006, 64:275-279.
3. Allison D., Denke M., Dietschy J., Emken E., Kris-Etherton P., Nicolosi R. Trans fatty acids and cononary heart disease risk. Report of the expert panel on trans fatty acids and coronary heart disease. Am J Clin Nutr 1995, 62:655S-708S.
4. Roach C., Feller S.E., Ward J.A., Shaikh S.R., Zerouga M., Stillwell W. Comparison of cis and trans fatty acid containing phosphatidylcholines on membrane properties. Biochem 2004, 43:6344-6351.
5. Schrock C.G., Connor W.E. Incorporation of the dietary trans fatty acid (C18:1) into the serum lipids, the serum lipoproteins and adipose tissue. Am J Clin Nutr 1975, 28:1020-1027.
6. Privett O.S., Phillips F., Shimasaki H., Nozawa T., Nickell E.C. Studies of effects of trans fatty acids in the diet on lipid metabolism in essential fatty acid deficient rats. Am J Clin Nutr 1971, 30:1009-1017.
7. Cook H.W. Incorporation, metabolism and positional distribution of trans-unsaturated fatty acids in developing and mature brain. Comparison of elaidate and oleate administered intracerebrally. Biochim Biophys Acta 1978, 531:245-256.
8. Emken E.A., Dutton H.J., Rohwedder W.K., Rakoff H., Adlof R.O. Distribution of deuterium-labeled cis- and trans-12-octadecenoic acids in human plasma and lipoprotein lipids. Lipids 1980, 15:864-871.
9. Blomstrand R., Diczfalusy U., Sisfontes L., Svensson L. Influence of dietary partially hydrogenated vegetable and marine oils on membrane composition and function of liver microsomes and platelets in the rat. Lipids 1985, 20:283-295.
10. Hoy C.E., Holmer G. Incorporation of cis- and trans-octadecenoic acids into the membranes of rat liver mitochondria. Lipids 2005, 14:727-733.
11. Niu S.L., Mitchell D.C., Litman B.J. Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs. Biochem 2005, 44:4458-4465.
12. Mozaffarian D., Katan M.B., Ascherio A., Stampfer M.J., Willett W.C. Trans fatty acids and cardiovascular disease. N Engl J Med 2006, 354:1601-1613.
13. Motard-Belanger A., Charest A., Grenier G., Paquin P., Chouinard Y., Lemieux S., et al. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 2008, 87:593-599.
14. Roberts A.B. Molecular and cell biology of TGF-β. Miner Electrolyte Metab 1998, 24:111-119.
15. Metcalfe J.C., Grainger D.J. Transforming growth factor-β and the protection from cardiovascular injury hypothesis. Biochem Soc Transact 1995, 23:403-406.
16. Grainger D.J., Kempt P.R., Metcalfe J.C., Liu A.C., Lawn R.M., Williams N.R., et al. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nat Med 1995, 1:74-79.
17. Mallat Z., Gojova A., Marchiol-Fournigault C., Esposito B., Kamate C., Merval R., et al. Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Cir Res 2001, 89:930-934.
18. Stefoni S., Cianciolo G., Donati A., Silvestri M.G., Coli L., De Pascalis A., et al. Low TGF-β1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Kidney Int 2002, 61:324-335.
19. Grainger D.J. Transforming growth factor β and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol 2004, 24:399-404.
20. Bobik A. Transforming growth factor-βs and vascular disorders. Arterioscler Thromb Vasc Biol 2006, 26:1712-1720.
21. Frutkin A.D., Ostuka G., Stempien-Otero A., Sesti C., Du L., Jaffe M., et al. TGF-β1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2009, 29:1251-1257.
22. Robertson A.K., Rudling M., Zhou X., Gorelik L., Flavell R.A., Hansson G.K. Disruption of TGF-β signaling in T cells accelerates atherosclerosis. J Clin Invest 2003, 112:1342-1350.
23. Chen C.-L., Liu I.-H., Fliesler S.J., Han X., Huang S.S., Huang J.S. Cholesterol suppresses cellular TGF-β responsiveness: implications in atherogenesis. J Cell Sci 2007, 120:3509-3521.
24. Chen C.-L., Huang S.S., Huang J.S. Cholesterol modulates cellular TGF-beta responsiveness by altering TGF-β binding to TGF-β receptors. J Cell Physiol 2008, 215:223-233.
25. Tetri L.H., Basaranoglu M., Brunt E.M., Yerian L.M., Neuschwander-Tetri B.A. Severe NAFLD with hepatic necroinflammatory changes in sedentary mice fed trans-fats and high fructose syrup equivalent. Am J Physiol Gastrointest Liver Physiol 2008, 295:G987-995.
26. Di Guglielmo G.M., Le Roy C., Anne F., Goodfellow A.F., Wrana J.A. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nat Cell Biol 2003, 5:410-421.
27. Ito T., Williams J.D., Fraser D.J., Phillips A.O. Hyaluronan regulates transforming growth factor-β1 receptor compartmentalization. J Biol Chem 2004, 279:25326-25332.
28. Huang S.S., Huang J.S. TGF-β control of cell proliferation (Prospect). J Cell Biochem 2005, 96:447-462.
29. Chen C.-L., Huang S.S., Huang J.S. Cellular heparan sulfate negatively modulates transforming growth factor-β responsiveness. J Biol Chem 2006, 281:11506-11514.
30. Chen Y.-G. Endocytic regulation of TGF-β signaling. Cell Res 2009, 19:58-70.
31. Heldin C.H., Miyazono K., ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 1997, 390:465-471.
32. Massague J. TGF-β signal transduction. Ann Rev Biochem 1998, 67:753-791.
33. Nakashima Y., Raines E.W., Plump A.S., Breslow J.L., Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998, 18:842-851.
34. Vega-López S., Matthan N.R., Ausman L.M., Ai M., Otokozawa S., Schaefer E.J., et al. Substitution of vegetable oil for a partially-hydrogenated fat favorably alters cardiovascular disease risk factors in moderately hypercholesterolesterolemic postmenopausal women. Atheroscler 2009, 207:208-212.
35. Lichtenstein A.H., Erkkila A.T., Lamarche B., Schwab U.S., Jalbert S.M., Ausman L.M. Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C- reactive protein. Atheroscler 2003, 171:97-107.
36. Chen C.-L., Hou W.H., Liu I.-H., Huang S.S., Huang J.S. Inhibitors of clathrin-dependent endocytosis inhibitors enhance signaling and responses. J Cell Sci 2009, 122:1863-1871.
37. Katz A.M. Should trans fatty acids be viewed as membrane-active drugs?. Atheroscler Suppl 2006, 7:41-42.
38. Ibrahim A., Natrajan S., Ghafoorunissa R. Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats. Metab Clin Exp 2005, 54:240-246.